There are many different varieties of monoclonal antibodies. They - like the vaccines - are EUA.
I had Bamlanivimab infused in March. Pain level went from a 7 to a 3 in hours.
It’s still experimental. They took Bamlanivimab off the market already.
That is only partially true (if I may be allowed to do some "fact-checking"). Here is the FDA revocation dated 16 April 2021:
In response to a request from Eli Lilly and Company, the U.S. Food and Drug Administration (FDA) has revoked the Emergency Use Authorization (EUA) of bamlanivimab alone for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) (EUA 90). Lilly made this request because there is now adequate supply of etesevimab for administration with bamlanivimab, and the combination neutralizes more of the emerging COVID-19 variants in the U.S. than bamlanivimab alone.Here is the replacement EUA for combined injection of bamlanivimab 700 mg/20 mL and etesevimab 700 mg / 20 mL.As a result, bamlanivimab alone is no longer authorized for use in the U.S., given the availability of authorized monoclonal antibody combinations. Importantly, revocation of the bamlanivimab alone (EUA 90) is not due to any new safety concerns.
I'm glad it worked so well for you!